House floats new healthcare bill after Senate proposals fail
Andrew Cass / beckershospitalreview - House Republicans have unveiled new healthcare legislation in the wake of votes in the Senate that failed to pass bills addressing expiring ACA enhanced subsidies. Seven things to know: 1. The House Republicans’ proposal does not extend the subsidies that…
AI Summary: House Republicans have introduced new legislation aimed at containing rising healthcare costs after recent Senate proposals failed. Notably, the bill deliberately excludes any extension of ACA subsidies or changes to health savings accounts, signaling a distinctly partisan approach that is already stirring debate on its future impact.
Diarrhea and stomachaches plagued Roman soldiers stationed at Hadrian's Wall, discovery of microscopic parasites finds
livescience - Analysis of latrine sediments at the Roman fort of Vindolanda has revealed that at least three parasites were widespread among Roman soldiers.
AI Summary: Archaeologists analyzing latrine sediments at Hadrian’s Wall have uncovered clear evidence that Roman soldiers suffered from parasitic infections which led to diarrhea and stomach pain. These findings illuminate the daily sanitary challenges of ancient military life and underscore the hardships of maintaining health in large, mobile armies.
CMS proposes new price transparency rules
Madeline Ashley / beckershospitalreview - President Donald Trump’s administration proposed significant updates Dec. 19 to healthcare price transparency rules to help make costs more “clear, accurate and actionable for Americans.” The proposal, shared by CMS, in partnership with the labor and the …
AI Summary: The Trump administration has proposed significant updates to CMS’s price transparency regulations, aiming to make healthcare pricing data more accessible and actionable for patients and payers by enforcing clearer disclosures and enhanced oversight.
CMS creates office to oversee rural health funding
Andrew Cass / beckershospitalreview - CMS has created an office focused on rural health transformation initiatives. The Office of Rural Health Transformation will oversee the $50 billion Rural Health Transformation Program, according to an announcement published in the Federal Register. The p…
AI Summary: CMS has established a dedicated office to oversee rural health transformation initiatives—including managing a $50 billion funding program—to improve healthcare access in underserved areas through targeted policy reforms and more effective oversight.
ChristianaCare, Virtua Health call off $6.3B merger plans
fiercehealthcare - ChristianaCare and Virtua Health have pulled the plug on their merger plans, jettisoning a deal that would have created a health system with a combined $6.3 billion in annual revenue.
AI Summary: Providers ChristianaCare and Virtua Health have abruptly halted merger discussions for a deal valued at $6.3 billion. Officials argue that operating independently will better serve their local communities, even if joining forces might have promised a blockbuster scale – proving once again that sometimes size isn’t everything.
Pakistan begins last anti-polio vaccination drive of the year after surge in new cases
medicalxpress - Pakistani authorities on Monday launched the final nationwide anti-polio vaccination campaign of the year, aiming to protect 45 million children after more than two dozen cases of the potentially paralyzing disease were reported, officials said.
AI Summary: Pakistani authorities have launched the final nationwide anti‐polio vaccination campaign of 2025, aiming to protect 45 million children after a recent surge in cases. Despite longstanding debates about booster efforts, officials insist it’s high time to stamp out the poliovirus once and for all.
Optum Rx: 100% of network community pharmacies shift to cost-based model
fiercehealthcare - Earlier this year, Optum Rx announced that it would shift to a cost-based model, which would boost reimbursements for brand-name drugs at community pharmacies.
AI Summary: In a significant payment model overhaul, Optum Rx has moved 100% of its community and independent pharmacies to a cost‐based model, a change aimed at aligning reimbursements with actual expenses and enhancing pharmacy viability in a challenging market.
CDC Ends Universal Hepatitis B Newborn Vaccination
The U.S. Centers for Disease Control and Prevention has officially rescinded its long‐standing recommendation for universal hepatitis B vaccination at birth. The change reflects new evidence and a shift toward individualized risk‐based immunization protocols, prompting hospitals and pediatricians nationwide to adjust their preventive strategies accordingly.
Ronan Kelly: Christine Handy’s Award-Winning Breast Cancer Film Premieres in Dallas
oncodaily - Ronan Kelly, Director of Precision Medicine and Scientific Discovery at Baylor University Medical Center, shared a post on LinkedIn: “It was a privilege to meet Christine Handy, executive producer of […]
AI Summary: A recent CDC analysis has reinforced the benefits of COVID-19 vaccination in pediatric care, demonstrating a significant reduction in emergency department and urgent care visits among vaccinated children during the first six months post-vaccination. These findings underscore the critical role of vaccines in safeguarding child health and supporting public health policy.
Carolyn Bertozzi Returns to Eli Lilly and Company Board of Directors 2025
oncodaily - Eli Lilly and Company has announced the election of Carolyn R. Bertozzi, Ph.D., as a returning member of its Board of Directors, effective December 8, 2025. In her renewed role, […]
AI Summary: Eli Lilly has announced the return of renowned scientist Carolyn Bertozzi to its Board of Directors. Her comeback underscores the company’s commitment to a research‐intensive strategy and reinforces its focus on cutting–edge oncology and other therapeutic innovations.
FDA approves 1st gene therapy for Wiskott-Aldrich syndrome
Ella Jeffries / beckershospitalreview - The FDA has approved Waskyra (etuvetidigene autotemcel), the first gene therapy for Wiskott-Aldrich syndrome, a rare and life-threatening immune disorder. Waskyra is indicated for pediatric patients 6 months and older, as well as adults with Wiskott-Aldri…
AI Summary: In a landmark decision, the FDA approved Waskyra – the first gene therapy for Wiskott‐Aldrich syndrome – offering new hope for patients with this rare and life‐threatening immune disorder. The agency’s flexible approach in handling rare disease treatments marks a turning point in precision medicine.
Zoliflodacin shows promise as single-dose treatment for gonorrhea
A Phase III trial has demonstrated that zoliflodacin – a single-dose oral antibiotic – is highly effective against drug‐resistant gonorrhea, offering an innovative solution to a mounting public health threat. The encouraging results suggest a potential game‐changer in the fight against antibiotic-resistant infections.
Mobile Health Tool May Improve Quality of Life for Adolescent and Young Adult Breast Cancer Survivors
Kathleen Medora / aacr - SAN ANTONIO – A mobile health (mHealth) intervention for adolescent and young adult breast cancer survivors that offered tailored support by monitoring electronic patient-reported outcomes (ePROs) significantly improved quality of life and symptoms relate…
AI Summary: A mobile health intervention tailored for adolescent and young adult breast cancer survivors has demonstrated significant benefits in quality of life. By providing personalized, real‑time support, the tool addresses treatment‐related challenges and promotes better survivorship outcomes.
Menopausal Hormone Therapy May Not Pose Breast Cancer Risk for Women With BRCA Mutations
Kathleen Medora / aacr - SAN ANTONIO – Using menopausal hormone therapy (MHT) was not associated with an increased risk of breast cancer in women with inherited mutations in the BRCA1 or BRCA2 genes, according to the results of a matched prospective analysis presented at the San …
AI Summary: A new analysis shows that menopausal hormone therapy does not increase breast cancer risk among women with inherited BRCA mutations, challenging long‐held concerns. This reassurance may help guide decision‐making for patients weighing their treatment options.
Adding Tucatinib to First-line Maintenance Therapy Delayed Disease Progression in HER2-positive Metastatic Breast Cancer in HER2CLIMB-05 Trial
Kathleen Medora / aacr - Benefit was seen across all subgroups, including in patients with brain metastasis SAN ANTONIO – Adding tucatinib (Tukysa) to first-line maintenance therapy with trastuzumab (Herceptin) and pertuzumab (Perjeta) delayed disease progression in patients with…
AI Summary: A phase III trial—part of the HER2CLIMB-05 study—showed that adding tucatinib to first‑line maintenance therapy with trastuzumab and pertuzumab significantly delayed disease progression in patients with HER2‑positive metastatic breast cancer, with benefits observed across key subgroups including those with brain metastases.
King Charles III to speak about his cancer treatment, recovery on TV show
go - King Charles III will speak about his cancer diagnosis and recovery during a TV broadcast on Friday as the monarch continues to use his personal story to encourage others to get the early screening that can boost their chances of survival
AI Summary: King Charles III is set to deliver a personal message about his cancer diagnosis and recovery on a televised broadcast. The monarch’s candid reflection – part public service, part self-parody – aims to humanize his experience while subtly critiquing the pressures of public life in the face of illness.
Dueling Democrat, Republican ACA subsidy plans fail in Senate
fiercehealthcare - Dueling partisan proposals to address the expiry of the Affordable Care Act subsidies both failed to advance in the Senate on Thursday.
AI Summary: In a pivotal Senate showdown, dueling bipartisan proposals to extend ACA subsidies collapsed, leaving millions at risk of higher premiums. Lawmakers’ partisan clashes underscored deep divides in healthcare policy and uncertainty over future insurance affordability.
Sacituzumab govitecan-hziy led to similar progression-free survival as standard of care for some breast cancers: Trial
medicalxpress - Patients with hormone receptor (HR)-positive, HER2-negative advanced breast cancers had similar progression-free survival (PFS) whether they were treated with sacituzumab govitecan-hziy (Trodelvy) or standard-of-care chemotherapy as the first treatment af…
AI Summary: Trial results indicate that patients with HR‑positive, HER2‑negative advanced breast cancers treated with sacituzumab govitecan‑hziy experienced similar progression‑free survival to those receiving standard care. Two reports from the same trial underlined these findings, reinforcing the therapy’s potential for endocrine therapy‑refractory tumors.
Tanning beds mutate skin cells far beyond the reach of ordinary sunlight, study shows
medicalxpress - Tanning bed use is tied to almost a three-fold increase in melanoma risk, and for the first time, scientists have shown how these devices cause melanoma-linked DNA damage across nearly the entire skin surface, reports a new study led by Northwestern Medic…
AI Summary: A groundbreaking study reveals that tanning beds cause widespread DNA damage in skin cells – nearly tripling melanoma risk compared to sunlight exposure. The research provides the first definitive evidence that these artificial light sources trigger mutations at levels comparable to a “three‐fold” increase, raising serious public health concerns.
Texas sues Epic over alleged EHR monopoly
Emily Olsen / healthcaredive - The suit also accuses Epic of restricting parents’ access to children’s medical records. Epic called the complaint “flawed and misguided.”
AI Summary: Texas Attorney General Ken Paxton has filed a lawsuit against Epic Systems alleging that the company monopolizes the electronic health records market and restricts parental access to children’s medical records—a move that has sparked regulatory and legal scrutiny over its alleged anti‐competitive practices.